Internal Medicine, Medical Oncology · Evanston, IL
NPI
1689607152
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2650 Ridge Ave., Kellogg Cancer Center
Evanston, IL, 60201
Phone (847) 570-2112
Groups this clinician bills Medicare through
Medicare paid, 2024
$96K
1,182 services
Medicare patients, 2024
352
Average age 78
Drug cost, 2024
$4.7M
1,431 prescriptions
Company payments, 2025
$71.03
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel H Shevrin was code 99214 (office e&m - established), 624 times for 209 patients. In total Daniel H Shevrin billed 1,182 services in 15 codes, and Medicare paid $96K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 624 | 209 | $80.76 | $50K |
| 99213 Office E&M - Established | Office | 278 | 138 | $60.64 | $17K |
| 99215 Office E&M - Established | Office | 112 | 63 | $126.03 | $14K |
| 99442 Telephone Services | Office | 33 | 27 | $61.68 | $2,036 |
| 99204 Office E&M - New | Office | 28 | 28 | $110.01 | $3,080 |
| 99443 Telephone Services | Office | 26 | 20 | $83.91 | $2,182 |
| 99205 Office E&M - New | Office | 22 | 22 | $155.64 | $3,424 |
| 99441 Telephone Services | Office | 20 | 16 | $33.41 | $668 |
| 99232 Hospital E&M - Subsequent | Facility | 17 | 14 | $66.61 | $1,132 |
By year: 2022 $88K for 1,259 services; 2023 $92K for 1,266 services; 2024 $96K for 1,182 services.
Medicare prescription drug claims, 2024
In 2024, the drug Daniel H Shevrin prescribed most often to Medicare patients was Abiraterone Acetate, with 424 prescriptions and refills. In total Daniel H Shevrin wrote 1,431 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 424 | 482 | 57 | $381K |
| Prednisone Generic | 284 | 379 | 56 | $2,110 |
| Erleada Apalutamide | 106 | 128 | 14 | $1.8M |
| Xtandi Enzalutamide | 98 | 106 | 15 | $982K |
| Dexamethasone Generic | 74 | 104 | 19 | $640 |
| Gabapentin Generic | 63 | 119 | 16 | $1,192 |
| Potassium Chloride Generic | 51 | 101 | 16 | $967 |
| Bicalutamide Generic | 40 | 108 | Under 11 | $1,151 |
| Nubeqa Darolutamide | 35 | 35 | Under 11 | $477K |
| Orgovyx Relugolix | 34 | 34 | Under 11 | $88K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 26 | 26 | Under 11 | $629 |
| Tamsulosin Hcl Generic | 18 | 48 | Under 11 | $593 |
| Tramadol Hcl Generic | 16 | 16 | Under 11 | $133 |
| Prochlorperazine Maleate Generic | 16 | 16 | 13 | $158 |
| Votrient Pazopanib Hcl | 14 | 14 | Under 11 | $250K |
Brand drugs: 336 claims; generic drugs: 1,095 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel H Shevrin $71.03 ($71.03 in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $71.03.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $71.03 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.